Tokyo's experiential robot developer Telexistence has won funding from a investors including the university's Innovation Platform and a host of corporates.
Backed by investors including BDC Capital, Toronto-founded Blue J Legal hopes to adapt its legal forecasting technology to the US system.
The KCL immuno-oncology spinout’s second series A close included investment from UCL Technology Fund, Alsa Holding and Epidarex Capital.
Tactiva, an immuno-oncology spinout of Roswell Park Comprehensive Cancer Center and based at University of Buffalo, will use the funding to drive its development program.
UCL spinout Engitix plans to develop therapeutics for liver fibrosis and certain cancers based on its targeted drug discovery platform.
The company has raised $14.4m from investors including Tsinghua University’s THG Ventures for its range of integrated circuit design services.
Paris Saclay Seed Fund backed a series A round which will help the biotechnology company expand sales and launch a new product.
Provided by Matrix Partner China and Ceyuan Ventures, the series A capital will help Renmin natural language processing spinout Elens mature its product development and R&D capabilities.